Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

The Structure of the Type III Secretion System Needle Complex.

Miletic S, Goessweiner-Mohr N, Marlovits TC.

Curr Top Microbiol Immunol. 2019 Oct 31. doi: 10.1007/82_2019_178. [Epub ahead of print]

PMID:
31667599
2.

Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site.

Wald J, Pasin M, Richter M, Walther C, Mathai N, Kirchmair J, Makarov VA, Goessweiner-Mohr N, Marlovits TC, Zanella I, Real-Hohn A, Verdaguer N, Blaas D, Schmidtke M.

Proc Natl Acad Sci U S A. 2019 Sep 17;116(38):19109-19115. doi: 10.1073/pnas.1904732116. Epub 2019 Aug 28.

PMID:
31462495
3.

High-throughput stability screening for detergent-solubilized membrane proteins.

Kotov V, Bartels K, Veith K, Josts I, Subhramanyam UKT, Günther C, Labahn J, Marlovits TC, Moraes I, Tidow H, Löw C, Garcia-Alai MM.

Sci Rep. 2019 Jul 17;9(1):10379. doi: 10.1038/s41598-019-46686-8.

4.

Control of type III protein secretion using a minimal genetic system.

Song M, Sukovich DJ, Ciccarelli L, Mayr J, Fernandez-Rodriguez J, Mirsky EA, Tucker AC, Gordon DB, Marlovits TC, Voigt CA.

Nat Commun. 2017 May 9;8:14737. doi: 10.1038/ncomms14737.

5.

Structure of the mycobacterial ESX-5 type VII secretion system membrane complex by single-particle analysis.

Beckham KS, Ciccarelli L, Bunduc CM, Mertens HD, Ummels R, Lugmayr W, Mayr J, Rettel M, Savitski MM, Svergun DI, Bitter W, Wilmanns M, Marlovits TC, Parret AH, Houben EN.

Nat Microbiol. 2017 Apr 10;2:17047. doi: 10.1038/nmicrobiol.2017.47.

PMID:
28394313
6.

Structural and Functional Characterization of the Bacterial Type III Secretion Export Apparatus.

Dietsche T, Tesfazgi Mebrhatu M, Brunner MJ, Abrusci P, Yan J, Franz-Wachtel M, Schärfe C, Zilkenat S, Grin I, Galán JE, Kohlbacher O, Lea S, Macek B, Marlovits TC, Robinson CV, Wagner S.

PLoS Pathog. 2016 Dec 15;12(12):e1006071. doi: 10.1371/journal.ppat.1006071. eCollection 2016 Dec.

7.

A cooperative mechanism drives budding yeast kinetochore assembly downstream of CENP-A.

Hornung P, Troc P, Malvezzi F, Maier M, Demianova Z, Zimniak T, Litos G, Lampert F, Schleiffer A, Brunner M, Mechtler K, Herzog F, Marlovits TC, Westermann S.

J Cell Biol. 2014 Aug 18;206(4):509-24. doi: 10.1083/jcb.201403081.

8.

Bacterial type III secretion systems: specialized nanomachines for protein delivery into target cells.

Galán JE, Lara-Tejero M, Marlovits TC, Wagner S.

Annu Rev Microbiol. 2014;68:415-38. doi: 10.1146/annurev-micro-092412-155725. Epub 2014 Jun 18. Review.

9.

Structure of a pathogenic type 3 secretion system in action.

Radics J, Königsmaier L, Marlovits TC.

Nat Struct Mol Biol. 2014 Jan;21(1):82-7. doi: 10.1038/nsmb.2722. Epub 2013 Dec 8.

PMID:
24317488
10.

Protein-mediated transformation of lipid vesicles into tubular networks.

Simunovic M, Mim C, Marlovits TC, Resch G, Unger VM, Voth GA.

Biophys J. 2013 Aug 6;105(3):711-9. doi: 10.1016/j.bpj.2013.06.039.

11.

The blueprint of the type-3 injectisome.

Kosarewicz A, Königsmaier L, Marlovits TC.

Philos Trans R Soc Lond B Biol Sci. 2012 Apr 19;367(1592):1140-54. doi: 10.1098/rstb.2011.0205. Review.

12.

Induced heterodimerization and purification of two target proteins by a synthetic coiled-coil tag.

Fernandez-Rodriguez J, Marlovits TC.

Protein Sci. 2012 Apr;21(4):511-9. doi: 10.1002/pro.2035. Epub 2012 Feb 23.

13.

Three-dimensional model of Salmonella's needle complex at subnanometer resolution.

Schraidt O, Marlovits TC.

Science. 2011 Mar 4;331(6021):1192-5. doi: 10.1126/science.1199358.

14.

Entry of a heparan sulphate-binding HRV8 variant strictly depends on dynamin but not on clathrin, caveolin, and flotillin.

Khan AG, Pickl-Herk A, Gajdzik L, Marlovits TC, Fuchs R, Blaas D.

Virology. 2011 Mar 30;412(1):55-67. doi: 10.1016/j.virol.2010.12.042. Epub 2011 Jan 22.

15.

Organization and coordinated assembly of the type III secretion export apparatus.

Wagner S, Königsmaier L, Lara-Tejero M, Lefebre M, Marlovits TC, Galán JE.

Proc Natl Acad Sci U S A. 2010 Oct 12;107(41):17745-50. doi: 10.1073/pnas.1008053107. Epub 2010 Sep 27.

16.

Topology and organization of the Salmonella typhimurium type III secretion needle complex components.

Schraidt O, Lefebre MD, Brunner MJ, Schmied WH, Schmidt A, Radics J, Mechtler K, Galán JE, Marlovits TC.

PLoS Pathog. 2010 Apr 1;6(4):e1000824. doi: 10.1371/journal.ppat.1000824.

17.

Human rhinovirus 14 enters rhabdomyosarcoma cells expressing icam-1 by a clathrin-, caveolin-, and flotillin-independent pathway.

Khan AG, Pickl-Herk A, Gajdzik L, Marlovits TC, Fuchs R, Blaas D.

J Virol. 2010 Apr;84(8):3984-92. doi: 10.1128/JVI.01693-09. Epub 2010 Feb 3.

18.

The structure of the Salmonella typhimurium type III secretion system needle shows divergence from the flagellar system.

Galkin VE, Schmied WH, Schraidt O, Marlovits TC, Egelman EH.

J Mol Biol. 2010 Mar 12;396(5):1392-7. doi: 10.1016/j.jmb.2010.01.001. Epub 2010 Jan 11.

19.

Type III secretion systems shape up as they ship out.

Marlovits TC, Stebbins CE.

Curr Opin Microbiol. 2010 Feb;13(1):47-52. doi: 10.1016/j.mib.2009.11.001. Epub 2009 Dec 16. Review.

20.

Assembly of the inner rod determines needle length in the type III secretion injectisome.

Marlovits TC, Kubori T, Lara-Tejero M, Thomas D, Unger VM, Galán JE.

Nature. 2006 Jun 1;441(7093):637-40.

PMID:
16738660
21.

Structural insights into the assembly of the type III secretion needle complex.

Marlovits TC, Kubori T, Sukhan A, Thomas DR, Galán JE, Unger VM.

Science. 2004 Nov 5;306(5698):1040-2.

22.

The membrane protein FeoB contains an intramolecular G protein essential for Fe(II) uptake in bacteria.

Marlovits TC, Haase W, Herrmann C, Aller SG, Unger VM.

Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16243-8. Epub 2002 Nov 22.

23.
24.

The cellular receptor to human rhinovirus 2 binds around the 5-fold axis and not in the canyon: a structural view.

Hewat EA, Neumann E, Conway JF, Moser R, Ronacher B, Marlovits TC, Blaas D.

EMBO J. 2000 Dec 1;19(23):6317-25.

25.

Crystallization and preliminary X-ray analysis of human rhinovirus serotype 2 (HRV2).

Verdaguer N, Marlovits TC, Bravo J, Stuart DI, Blaas D, Fita I.

Acta Crystallogr D Biol Crystallogr. 1999 Aug;55(Pt 8):1459-61.

26.

Recombinant soluble low-density lipoprotein receptor fragment inhibits common cold infection.

Marlovits TC, Zechmeister T, Schwihla H, Ronacher B, Blaas D.

J Mol Recognit. 1998 Winter;11(1-6):49-51.

PMID:
10076805
27.

Soluble LDL minireceptors. Minimal structure requirements for recognition of minor group human rhinovirus.

Marlovits TC, Abrahamsberg C, Blaas D.

J Biol Chem. 1998 Dec 11;273(50):33835-40.

28.
29.

Recombinant soluble low density lipoprotein receptor fragment inhibits minor group rhinovirus infection in vitro.

Marlovits TC, Zechmeister T, Gruenberger M, Ronacher B, Schwihla H, Blaas D.

FASEB J. 1998 Jun;12(9):695-703.

PMID:
9619448
30.

Structure of a neutralizing antibody bound monovalently to human rhinovirus 2.

Hewat EA, Marlovits TC, Blaas D.

J Virol. 1998 May;72(5):4396-402.

Supplemental Content

Loading ...
Support Center